Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
Child, Adult, Senior
Sexes Eligible for Study:
Cancer patients in palliative care
Patients fully informed about their condition
Signed informed consent
No exclusion criteria
Absence of advanced cancer
Cancer previously cured
Venous thromboembolism diagnosed within 6 months prior to inclusion
Absence of discerning capacity
Active anti-thrombotic treatment with heparins or coumarines